Karen Gibson has become senior vice president of information technology and chief information officer, and Nicolas Barthelemy has become senior vice president of global operations of Invitrogen. Most recently, Gibson was vice president of global e-business and chief information officer at General Electric’s Medical Systems Information Technologies division. She holds an MBA from Ohio University and a BS in computer technology from Purdue University. Barthelemy joins Invitrogen from Biogen, where he was vice president of manufacturing and general manager of the company’s Research Triangle Park site. He holds a degree in mathematics, physics, and chemistry from the Ecole Superieure de Physiques et Chimie Industrielles in France, and a master’s of science in chemical engineering from the University of California at Berkeley.
Indiana life sciences consortium BioCrossroads announced its board of directors. The board includes: August Watanabe, Craig Brater, Robert Compton, Kathy Davis, Daniel Evans, David Goodrich, Adam Herbert, Marin Jischke, David Johnson, Wade Lange, Beverly Lorell, Martin Madaus, Samuel Nussbaum, Steven Paul, Jerome Peribere, Bart Peterson, Daniel Peterson, Charles Rutledge, and Charles Schalliol.
Brian Beatty has been appointed to the scientific/educational advisory board of San Francisco electronic teaching firm GeneEd. Beatty is an assistant professor in the instructional technology department at San Francisco State University, where he leads an e-learning program. He holds a PhD in instructional systems technology from Indiana University Bloomington and an MA in instructional technologies from San Francisco State University, as well as a BS in electrical engineering from Marquette University.
Michael Avallone has become chief financial officer of Boston Biomedica. Avallone was previously corporate controller of the company. Prior to that, he worked at NSTAR and at PricewaterhouseCoopers.
Rudolph Potenzone was named senior vice president of business development and strategic planning at Ingenuity. He comes to the firm from Lion Bioscience, where he was CEO of its US subsidiary. Potenzone holds a PhD in macromolecular science from Case Western Reserve University and a bachelor of science in biophysics and microbiology from the University of Pittsburgh.